AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Wyeth bone mineral density screening program shows high percentage of women at risk.(Wyeth Pharmaceuticals Proprietary Ltd.)(Brief Article)

Women's Health Weekly

| July 18, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 JUL 18 - (NewsRx.com & NewsRx.net) -- More than 6% of the 49,000 women screened in the pilot year of Wyeth Pharmaceuticals' (WYE)) bone mineral density (BMD) screening program were at high or moderate risk of developing osteoporosis and possibly a related fracture. By the end of 2002, the program will have offered a free BMD test to more than 70,000 women across the country.

"Identifying early menopausal bone loss is critical to halting the onset and progression of osteoporosis," says Victoria Kusiak, MD, vice president of global medical affairs for Wyeth Pharmaceuticals. "It is important for a menopausal woman to talk with her doctor about her risk of menopausal bone loss and to quantify this risk through BMD ...

Related articles from newspapers, magazines, journals, and more
Wyeth Pharmaceuticals Announces First Year Update On Nationwide Bone Mineral...
Press release article from: Business Wire June 12, 2002 700+ words
...pilot year of Wyeth Pharmaceuticals' (a division...density (BMD) screening program were at high...Affairs for Wyeth Pharmaceuticals. "It is...Wyeth's BMD screening program uses quantitative...Kusiak. Wyeth Pharmaceuticals will continue...
Wyeth Pharmaceuticals Celebrates Grand Opening of Its New Global Headquarters;...
Press release article from: PR Newswire October 17, 2003 700+ words
...PRNewswire/ -- Opening ceremonies for Wyeth Pharmaceuticals' new state-of-the-art global...100 employees to the new site. Wyeth Pharmaceuticals purchased the Collegeville property...Collegeville began with the transfer of Wyeth Pharmaceuticals employees from existing sites in...
WYETH PHARMACEUTICALS, NAUTILUS BIOTECH ANNOUNCE COLLABORATION.
News wire article from: AsiaPulse News February 5, 2007 700+ words
...statement. Contact details below.) Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration...Commitment to Innovation in Hemophilia Wyeth Pharmaceuticals, a division of Wyeth, and Nautilus...Manager, BioPharma Business Unit at Wyeth Pharmaceuticals. Under the terms of this ...
Wyeth Pharmaceuticals Listed as the Best 10 Pipeline for the Third Consecutive...
Press release article from: PR Newswire January 29, 2007 700+ words
...29 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth, , announced...remain an industry leader." About Wyeth Pharmaceuticals Wyeth Pharmaceuticals has leading products in the areas of...
WYETH PHARMACEUTICALS, MEDIVAS PARTNER ON HEMOPHILIA THERAPIES.
News wire article from: AsiaPulse News February 6, 2007 700+ words
...advanced therapies for hemophilia, Wyeth Pharmaceuticals, a division of Wyeth (NYSE...Manager, BioPharma Business Unit at Wyeth Pharmaceuticals. Under the terms of the agreement...IX, respectively, for life. Wyeth Pharmaceuticals has leading products in the areas...
Wyeth Pharmaceuticals Receives Food and Drug Administration Approval for New...
Press release article from: PR Newswire September 13, 2004 700+ words
...Convenience to Hemophilia Community Wyeth Pharmaceuticals, a division of Wyeth , announced...President and Chief Medical Officer of Wyeth Pharmaceuticals. Wyeth anticipates that the ReFacto...hemophiliavillage.com/. About Wyeth Wyeth Pharmaceuticals, a division of Wyeth, has ...
Wyeth Pharmaceuticals Introduces Its First Training Kit to Help People With...
Press release article from: PR Newswire June 21, 2007 700+ words
...commitment to the hemophilia community, Wyeth Pharmaceuticals, a division of Wyeth , announced...President and Chief Medical Officer, Wyeth Pharmaceuticals. The comprehensive kit contains...at hemophiliavillage.com About Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a ...
Wyeth Pharmaceuticals Announces Termination of Phase 3 Clinical Program with...
Press release article from: PR Newswire March 16, 2006 700+ words
...PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced...President and Chief Medical Officer, Wyeth Pharmaceuticals. "We remain committed to studying...in phase 1 and phase 2 studies. Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA